Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Vytorin (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-3 of 3
» View herald-mail.com items only
    Nov 15, 2009 | Los Angeles Times

  1. Vytorin trial shows little or no benefit against heart disease [Updated]

    Booster Shots
    For the second time in as many years, a large clinical trial has found that the key ingredient in the heavily advertised drug Vytorin provides little or no benefit in preventing heart disease compared to a competing product. The ingredient......
    2. Dec 24, 2009 | Los Angeles Times

  2. FDA panel says Vytorin and Zetia probably don't cause cancer

    Booster Shots
    A comprehensive review of previous studies involving the cholesterol-lowering drugs Vytorin and Zetia and two large ongoing studies shows that "it is unlikely that [they] increase the risk of cancer or cancer-related deaths," a Food and Drug...
    3. Apr 7, 2008 |Story| Los Angeles Times

  3. A handle on heart disease?

    The cholesterol drug did absolutely everything it was supposed to do -- except for demonstrably improving the health of the people who took it.
    Los Angeles Times Staff Writer
    The cholesterol drug did absolutely everything it was supposed to do -- except for demonstrably improving the health of the people who took it. That was the conclusion reached about the popular drug Vytorin in a study published online last week in the...

    Tags: Health and Medical Professionals, Medical Research, University of California, Los Angeles, Los Angeles Times, Northwestern University

Original site for Vytorin (drug) topic gallery.